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Abstract
The aggregation of the 37-amino acid polypeptide islet amyloid polypeptide (IAPP, amylin), as 
either insoluble amyloid or as small oligomers, appears to play a direct role in the death of 
pancreatic β-islet cells in type 2 diabetes. It is believed that inhibiting the aggregation of IAPP 
may slow down, if not prevent entirely, the progression of this disease. Extracts of thirteen 
different common fruits were analyzed for their ability to prevent the aggregation of 
amyloidogenic IAPP. Thioflavin T binding, immuno-detection and circular dichroism assays were 
performed to test the in vitro inhibitory potential of each extract. Atomic force microscopy was 
used to visualize the formation of amyloid fibrils with and without each fruit extract. Finally, 
extracts were tested for their ability to protect living mammalian cells from the toxic effects of 
amyloid IAPP. Several fruits showed substantial ability to inhibit IAPP aggregation and protect 
living cells from toxic IAPP amyloid.
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1. Introduction
The natural products isolated from fruit extracts have been associated with many positive 
health benefits. These health benefits span a variety of fields, showing beneficial 
functionalities for anti-cancer (Chia-Hung, Chi-Chou, Hsu, Kao, & Wang, 2015; Olsson, 
Gustavsson, Andersson, Nilsson, & Duan, 2004; Zunino, Zhang, Seeram, & Storms, 2010), 
anti-aging (Shukitt-Hale, Carey, Jenkins, Rabin, & Joseph, 2007), and anti-obesity 
(Chaudhary et al., 2014) to name a few. Previous studies have indicated that several 
individual fruits are capable of inhibiting the formation of protein aggregates associated with 
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amyloid-linked diseases, such as Alzheimer’s disease and type 2 diabetes (Li, Jang, Sun, & 
Surh, 2004; Park; Zhu, Bickford, Sanberg, Giunta, & Tan, 2008). However, to the best of 
our knowledge, no study has been performed to directly compare the efficacy of multiple 
fruits, spanning several fruit families, at inhibiting amyloid formation. In this work, thirteen 
common fruits were analyzed for their ability to prevent the aggregation of amyloidogenic 
islet amyloid polypeptide (IAPP), the amyloid protein associated with the progression of 
type 2 diabetes. The natural propensity of IAPP to aggregate into toxic amyloidogenic 
species is believed to occur in a similar fashion as other amyloidogenic proteins, such as 
Aβ42 in Alzheimer’s disease and α-synuclein in Parkinson’s disease. Fruit extracts capable 
of inhibiting the aggregation of IAPP, considered one of the most amyloidogenic protein 
known (Cao, Abedini, & Raleigh, 2013a), are likely to function as inhibitors of other 
amyloid proteins as well (Montane, Klimek-Abercrombie, Potter, Westwell-Roper, & 
Verchere, 2012).
The incidence of type 2 diabetes within developed nations continues to increase. The 
American Diabetes Association estimates that 25.8 million Americans have diabetes 
(approximately 8.3% of the population ("Type 2 Diabetes Facts and Figures," 2011)), with 
nearly 2 million new cases diagnosed each year. While obesity is a factor in the 
development of type 2 diabetes, over 70% of obese people do not have diabetes, suggesting 
that other factors influence the progression of this disease (cdc-national center for health 
statistics, National Data Brief, No. 82, Jan 2012) (Ogden, Carroll, Kit, & Flegal; Ogden, 
Carroll, Kit, & Flegal).
One possible factor linked to the progression of type 2 diabetes is the aggregation of the 
amyloidogenic peptide islet amyloid polypeptide (IAPP) (Montane et al., 2012). This 37-
amino acid polypeptide is co-secreted from pancreatic β-islet cells with insulin. During the 
progression of type 2 diabetes, IAPP aggregates into a variety of different amyloidogenic 
states (Abedini & Schmidt, 2013; Apostolidou, Jayasinghe, & Langen, 2008; Hull, 
Westermark, Westermark, & Kahn, 2004; Kahn, Andrikopoulos, & Verchere, 1999). While 
the exact structure and nature of these aggregates remains to be determined, it is clear that 
some of these aggregates are highly toxic to cells (Andrews, Inayathullah, Jayakumar, & 
Malar, 2009; Cao et al., 2013b; Nanga, Brender, Xu, Veglia, & Ramamoorthy, 2008). For 
example, Eisenberg and coworkers recently suggested that the most toxic form of IAPP may 
self-assemble into a cylindrin structure (Laganowsky et al., 2012; Liu et al.). These 
oligomeric structures seem to be the toxic form of the amyloid proteins. While the exact 
mechanism of toxicity remains unknown, two theories suggest that the oligomers either (1) 
form pores in the cellular membranes or (2) disrupt cellular membranes through membrane 
fragmentation (Brender, Salamekh, & Ramamoorthy, 2012). Ramamoorthy and coworkers 
have used NMR to solve the structures of several human and rat IAPP peptides under a 
variety of conditions, including within micelles (Brender, Durr, Heyl, Budarapu, & 
Ramamoorthy, 2007; Brender et al., 2008; Nanga et al., 2009; 2008; Soong, Brender, 
Macdonald, & Ramamoorthy, 2009). Regardless of the exact structure of the IAPP 
aggregates, their toxicity to cells may be the root cause of the progression of type 2 diabetes 
(Ritzel, Meier, Lin, Veldhuis, & Butler, 2007). Likewise, the toxicity of these aggregates 
appears to preclude the use of β-cell transplantation therapies (Potter et al.). The possibility 
exists that preventing the formation of toxic IAPP aggregates could slow, if not prevent 
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entirely, the progression of type 2 diabetes. Additionally, inhibiting the formation of these 
toxic aggregates may make future pancreatic β-cell transplantation therapies a reality.
The fruits described in this study were chosen for analysis because of their abundant 
availability within the United States and their distribution across several different fruit 
families. Because of the considerable levels of carbohydrates within these fruits (a fact that 
prevents many diabetic patients from ingesting large amounts of these fruits on a regular 
basis), we chose an extraction method that removed over 99% of the carbohydrates from the 
samples. The resulting fruit extracts were tested for their in vitro ability to prevent the 
formation of amyloid aggregates and their ex vivo ability to protect living mammalian cells 
from toxic IAPP amyloid.
2. Materials and Methods
2.1 Preparation of Fruit Extracts
For each individual whole fruit, 100 grams was ground using a mortar and pestle in the 
presence of 100 mL of ethyl acetate. The resulting slurry was filtered and the ethyl acetate 
layer isolated. The ethyl acetate was removed via speed vacuum yielding approximately 8 
aliquots of dehydrated solid extracts. These dehydrated extracts were stored at −20°C. 
Extracts were rehydrated by resuspending each aliquot in 150 µL 20 mM tris buffer pH 7.40 
(standard solution) or 1.50 mL of the same buffer (yielding samples 10× diluted).
2.2 Preparation of IAPP stock solutions
IAPP stock solutions were prepared by dissolving 1 mg of synthetic amylin (Anaspec Corp. 
Fremont, CA, USA) in 8 mL of hexafluorisopropanol (HFIP, Sigma Aldrich, St. Louis, MO, 
USA). To fully disaggregate the IAPP, the sample was placed in a sonicating water bath for 
5 min. This stock solution was stored at −80°C for up to two months.
2.3 Thioflavin T binding (ThT) assays
HFIP was removed from the IAPP stock solution under speed-vacuum. The dry IAPP 
sample was resuspended in 20 mM tris buffer pH 7.40 containing each individual fruit 
extract. The final in-solution concentration of IAPP was 106 µM. Aggregation was initiated 
by incubating samples at 37°C with shaking (200 rpm). At designated time points, a 17 µL 
aliquot of each sample was removed and mixed with 663 µL of 50.0 µM thioflavin T in 20 
mM Tris buffer pH 7.40. The IAPP/thioflavin T mixture was incubated at room temperature 
in the dark for 2 min before recording the thioflavin T fluorescence emission spectrum 
(Ex450nm) using a Hitatchi F-7000 fluorescence spectrophotometer.
2.4 Atomic Force Microscopy (AFM)
Synthetic IAPP was prepared as described above and incubated with shaking in the presence 
of individual fruit extracts. After 40 min of incubation, 20 µL of each sample were deposited 
onto freshly cleaved mica. After incubation at room temperature for 5 min, the mica was 
washed with 200 µL sterile-filtered water and allowed to air dry. The samples were scanned 
using an MFP-3D atomic force microscope (Asylum Research, Santa Barbara, CA, USA) set 
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on A/C mode and a 240 µm silicon cantilever (Olympus Corporation of the Americas, PA, 
USA). Images shown are the raw data with no flattening.
2.5 Circular Dichroism (CD)
CD spectroscopy was performed using a J-815 CD Spectrometer (Jasco Inc, Easton, MD, 
USA) with quartz cuvettes of 1 mm pathlength. Samples were scanned from 190 nm to 250 
nm. In order to reduce interference by the fruit extracts, 10× diluted fruit samples were 
mixed with IAPP. The final in-solution IAPP concentration was 76.8 µM. IAPP, in the 
presence and absence of each fruit sample, was incubated for 40 min at 37°C with shaking 
(200 rpm). These rigorous conditions reproducibly yielded IAPP fibrils (visible with Atomic 
Force Microscopy) with CD spectra having a single minimum at 218 nm.
2.6 Immunoblot dot test
Samples of IAPP were incubated with individual fruit extracts as described in the thioflavin 
T assay above. At designated time intervals, 2uL of each IAPP sample (with or without a 
fruit extract) were placed on a nitrocellulose membrane. The resulting membrane was 
allowed to air dry before blocking in 2.5% BSA in TBST buffer for 1 h at room temperature. 
After blocking, the membrane was cut in half, with one half probed with Millipore’s A11 
antibody (AB9234) and the other half probed with Millipore’s Fibril OC antibody (AB2286) 
(Millipore, Billerica, MA, USA). Both antibodies were applied at a 1:1000 (v,v) dilution for 
1 h at room temperature. The membranes were washed three times for 5 min each with 
TBST buffer. The membranes were probed with donkey anti-rabbit secondary antibody 
conjugated to HRP (1:2000 v,v) for 1 h at room temperature. The membranes were washed 
three times with TBST buffer. A final wash with TBS for 5 min was conducted before 
developing using GE’s Amersham ECL reagent with a 10 min exposure time. Images were 
taken using the Bio-Rad Imaging System.
2.7 HeLa cell rescue
HeLa cells were incubated with 15 µM of synthetic IAPP prepared as described above. 
Equal amounts of HeLa cells were plated in triplicate and incubated overnight in 96-well 
plates. After 24 h, F-12K media with phenol red was replaced by DMEM/F12 (1:1 v,v) 
without phenol red. Hexafluoroisopropanol (HFIP) was evaporated from IAPP using a 
centrivap concentrator (LabOnco). IAPP was re-suspended in DMEM/F12 media, the pellets 
were then mixed into the media by vortexing (Vortex Genie Mixer) for 2 min. Stock 
solutions of each fruit extract were diluted with 25 mM Tris Buffer (pH 7.4) and added to 
the appropriate wells. The treated cells were incubated for 22 h at 37°C. Post-incubation, 
MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-tetrazolium bromide) was added into each 
well and incubated at 37°C for 2 h. Formazan crystals, formed on the bottom of the wells, 
were re-suspended in a solubilization buffer (20% SDS and 50% dimethylformamide). The 
absorbance in each well was taken at 570 nm using a BioRad 550 microplate reader. HeLa 
cells and media were obtained from ATCC. All incubations took place in a water jacketed 
incubator in 5% carbon dioxide at 37°C (Shell Lab). The average percentage of cell viability 
was calculated for each of the conditions.
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The ethyl-acetate extracts of several common fruits were analyzed to identify those having 
the greatest potential for inhibiting the aggregation of amyloidogenic IAPP. Each fruit 
extract was initially analyzed for its ability to prevent thioflavin-T (ThT) binding to IAPP 
(Figure 1). ThT binding is a facile method for detecting and quantifying amyloid formation. 
ThT shows little fluorescence emission when solubilized in an aqueous solution. However, 
ThT fluorescence increases in a concentration-dependent manner when in the presence of 
amyloid (LeVine, 1993).
IAPP is believed to form a variety of different amyloidogenic aggregates with varying 
degrees of cellular toxicity (Andrews et al., 2009; Gazit, 2005; Haataja, Gurlo, Huang, & 
Butler, 2008). IAPP with and without each fruit extract was probed with the A11 antibody 
and the Fibril OC antibody (Figure 2). The A11 antibody is an anti-oligomer antibody that 
specifically binds to small soluble oligomers, believed to be the more toxic form of IAPP 
amyloid. The Fibril OC antibody is an anti-fibril antibody that specifically binds to the 
fibrillar form of IAPP. Dark spots on the immuno-detection assays indicated the presence of 
the amyloidogenic species, while colorless spots and white spots both indicated the absence 
of amyloidogenic species.
A more direct method for assessing amyloid inhibition potential is through the visualization 
of amyloidogenic fibrils. Atomic force microscopy (AFM) was used to visualize the 
formation of amyloid fibrils in the presence and absence of each fruit extract (Figures 3 and 
4). The use of AFM allows for a direct detection of an amyloidogenic species in the 
presence and absence of each fruit extract. Likewise, circular dichroism (CD) spectroscopy 
was used to detect the conversion of unstructured IAPP peptides into the β-sheet-rich 
amyloidogenic species of IAPP (Figure 5). Finally, to test the ability of each fruit extract to 
protect living cells from IAPP, the MTT assay was performed using HeLa cells (Figure 6). 
The MTT levels of HeLa cells alone were set as 100%. The addition of IAPP (labeled as 
amylin) to the HeLa cells decreased the cell viability to 67% in less than 24 h. The 25mm 
Tris Buffer was tested to ensure that there was no conflict with cell viability.
4. Discussion
4.1 Thioflavin T binding
The time course data for ThT binding to IAPP amyloid (Figure 1) indicated that most of the 
fruit samples were capable of slowing and/or preventing the aggregation of IAPP under 
rigorous aggregate-forming conditions. The fruits showing the least inhibitory potential 
according to the ThT results were banana, pineapple, and lemon. The remaining fruit 
extracts showed significant inhibitory potential. Th T binding by amyloid is a useful 
diagnostic for gauging the ability of a potential therapeutic to prevent amyloid formation. 
However, it is possible that the lack of ThT fluorescence may be due to inhibition of ThT 
binding to the amyloid, rather than preventing amyloid formation (this has been 
experimentally observed in the case of EGCG competing with ThT for binding to IAPP) 
(Suzuki, Brender, Hartman, Ramamoorthy, & Marsh, 2012). For this reason, it is important 
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to conduct additional experiments to identify true amyloid inhibitors and potential 
therapeutic agents.
4.2 Immuno-detection
We chose to perform immuno-detection assays to identify the amyloid species being 
inhibited by each fruit extract. The results (Figure 2) indicated that several fruits (banana, 
tomato, mango and nectarine) had little inhibitory potential, while the remaining fruits 
displayed some ability to prevent IAPP amyloid formation. These results also suggest that 
both IAPP oligomers and fibrils were inhibited in the presence of most of the fruit extracts. 
The fruit extracts showing the greatest inhibitory potential from these immuno-detection 
assays were grape, strawberry, pomegranate and raspberry (all of which were strong 
inhibitors according to the ThT results in Figure 1).
4.3 Atomic force microscopy
AFM, a direct test that allows the visualization of amyloidogenic fibrils, provided evidence 
suggesting that some fruit extracts were stronger inhibitors than others. Due to the fact that 
significant amounts of fibrils were observed, several fruit extracts (banana, kiwi, lemon, 
mango, nectarine, strawberry, and tomato) showed little ability to inhibit IAPP fibril 
formation (Figure 3). IAPP fibrils were found on every AFM sample in the presence of these 
non-inhibiting fruits. The remaining fruit extracts (blackberry, blueberry, grape, pineapple, 
pomegranate, and raspberry) showed significant ability to inhibit fibril formation (Figure 4) 
compared to IAPP in the absence of inhibitors. In every sample tested, high concentrations 
of the fruit extracts prevented fibril formation (Figure 4). The strongest inhibitors of fibril 
formation were the pomegranate, raspberry and blueberry extracts. When diluted 100×, 
these three extracts still prevented fibril formation in all samples tested. Whereas, extracts of 
the other inhibitor fruits (blackberry, grape and pineapple) began to lose potency after a 10× 
dilution of the extract (minor amounts of fibrils could be seen – data not shown).
4.4 Circular Dichroism
Like most amyloidogenic proteins, it is believed that the conversion of IAPP to an 
amyloidogenic state involves the formation of β-sheet secondary structure. It is well 
documented that the fibrillar form of IAPP forms a cross β-structure perpendicular to the 
axis of the fibril. This conversion from unstructured peptide to β-sheet was monitored via 
circular dichroism spectroscopy (CD). As IAPP adopts the β-sheet structure indicative of 
amyloidogenic aggregates, the CD signal displays a local minima at 218 nm. Fruit extracts 
found to prevent the conversion of IAPP into β-sheet rich structures are shown in Figure 5A. 
The CD signal of IAPP after incubation in the presence of inhibitory extracts (blackberry, 
blueberry, lemon, mango, nectarine, raspberry and tomato) resembles the CD signal of IAPP 
prior to incubation (data not shown). The fruit extracts of banana and strawberry (Figure 5B) 
showed little ability to prevent the conversion to β-sheet rich structures. Several fruit 
extracts (pomegranate, pineapple, grape, and kiwi) possessed CD-active extracts that 
interfered with the IAPP signal.
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To test the potential of fruit extracts to protect living cells from toxic IAPP aggregates, the 
MTT assay was performed using HeLa cells (Figure 6). The MTT assay, which quantitates 
the oxidative capacity of HeLa cells after treatment with the respective fruit extract and/or 
IAPP, indicated that certain fruit extracts had greater protective qualities compared to others. 
The addition of nectarine, raspberry, and pineapple significantly rescued the HeLa cells (p < 
0.05, t-test) from the toxic effects of IAPP. Tomato and banana extracts demonstrated the 
least potential for rescuing cells from IAPP toxicity. Several fruit extracts (strawberry, 
blackberry, lemon and kiwi) seemed to hinder cellular viability even in the absence of IAPP.
5. Conclusions
This comparative study evaluated the ability of common fruit extracts to inhibit the 
aggregation of IAPP into toxic amyloid species. These results indicate that many fruits 
possess the potential to inhibit IAPP aggregation, but several fruits were found to have 
significantly greater inhibitory activity. The fruit extracts with the greatest overall ability to 
prevent amyloid aggregation and simultaneously protect living cells from IAPP toxicity 
were the berries, raspberry and blueberry. Also showing substantial inhibitory activity were 
the pomegranate and grape extracts. Conversely, the banana and kiwi extracts showed 
virtually no inhibitory activity. The remaining fruits tested possessed moderate activity, 
showing mixed levels of aggregation inhibition in the various experiments performed.
The use of ethyl acetate as the extraction solvent yielded two beneficial outcomes. First, 
over 99% of the total carbohydrate of each extract remained within the aqueous phase (data 
not shown). Therefore, this choice of extraction solvent removed over 99% of the total sugar 
content. Because individuals suffering from type 2 diabetes must control their sugar intake, 
this extraction process could be used to produce a therapeutically viable form of each fruit. 
Second, the use of ethyl acetate pulls out and concentrates polyhydroxylated phenols and 
catechins, classes of compounds believed to possess a range of positive health benefits, 
including inhibition of amyloid formation.
From these results, we believe it is unlikely that the inhibitory component(s) for each fruit 
extract are the same. In our studies, the extracts from raspberry, blueberry and blackberry all 
performed well and were considered strong inhibitors of amyloid formation. Both raspberry 
and blackberry contain a substantial amount of flavanols such as EGCG, a known inhibitor 
of IAPP aggregation (Cao & Raleigh, 2012; Tang, 2007). Conversely, blueberry contains 
very little EGCG and flavanol content, yet was found to be an equally good inhibitor 
compared to raspberry and blackberry. Likewise, the amyloid inhibitory potential of each 
fruit extract was not necessarily linked to the anti-oxidant content of each fruit. Grapes, one 
of the strongest inhibitors of IAPP aggregation, have roughly the same antioxidant content 
as nectarines, bananas, and kiwis, the worst performers in this study.
The folding (or misfolding) process proteins undergo in their transition into toxic amyloid is 
not yet fully understood. However, it is believed that despite their differences in amino acid 
sequences and compositions, the majority of amyloid proteins undergo a similar aggregation 
pathway that leads to structurally similar amyloidogenic aggregates. Because of this, it is 
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possible that substances capable of inhibiting the aggregation of one amyloid protein may 
also be capable of inhibiting others. Because IAPP is considered to be one of the most 
amyloidogenic proteins known, substances found to inhibit this amyloid protein may be 
potential therapeutics for other amyloid proteins, such as Aβ42 aggregation in Alzheimer’s 
disease or α-synuclein in Parkinson’s disease (Fox et al., 2010).
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• Comparative study to identify fruits having the greatest potential for preventing 
amyloid.
• Extraction system described for producing bioactive samples lacking 
carbohydrates.
• Several fruit extracts protected living cells from high doses of toxic IAPP.
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Thioflavin T fluorescence of IAPP alone and IAPP in the presence of each fruit extract. 
Fluorescence was measured with an excitation wavelength of 450 nm and an emission 
wavelength of 488 nm. The solution concentration of IAPP was 106 µM for each sample. 
Data is the average of at least three data sets.
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Immunoblot dot test. Samples containing IAPP alone or IAPP with each fruit extract were 
incubated at 37°C with shaking (200 rpm). 2 µL of each sample was dotted onto 
nitrocellulose membrane and probed with A11 antibody (top panels) or Fibril OC antibody 
(bottom panels). Dark spots indicate where the amyloid-binding antibodies detected amyloid 
deposits. Blank and light spots indicate where amyloid was not present.
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Atomic force microsope images of fruits showing modest to negligible ability to inhibit 
IAPP fibril formation. a) IAPP alone b) banana c) kiwi d) lemon e) mango f) nectarine g) 
strawberry h) tomato.
Kao et al. Page 14














Atomic force microsope images of fruits showing significant ability to inhibit IAPP fibril 
formation. a) IAPP alone b) blackberry c) blueberry d) grape e) pineapple f) pomegranate g) 
raspberry.
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Circular Dichroism of IAPP after 40 minute incubation. (a) Fruits showing significant 
ability to prevent the conversion of IAPP to β-sheet conformation (b) Fruits showing 
negligible ability to prevent the conversion of IAPP to β-sheet conformation and (c) Fruits 
with UV-active extracts that interfered with monitoring of the IAPP β-sheet transition.
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Relative cell viability (%) in the presence of IAPP and/or fruit extracts. The “Media” and 
“Buffer” samples represent cell viability in the presence of media alone and media with Tris 
Buffer respectively (no IAPP was included in these samples). “Amylin” shows the effect of 
IAPP on cell viability. Grey bars indicate samples with IAPP and the specified fruit extract. 
White bars correspond to the effect of each individual fruit extract alone (with no IAPP 
present) on the viability of cells.
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